322 related articles for article (PubMed ID: 11811381)
1. Nitric oxide inhibition and renal alterations.
Jover B; Mimran A
J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S65-70. PubMed ID: 11811381
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
Eshima K; Hirooka Y; Shigematsu H; Matsuo I; Koike G; Sakai K; Takeshita A
Hypertension; 2000 Aug; 36(2):259-63. PubMed ID: 10948087
[TBL] [Abstract][Full Text] [Related]
4. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
[TBL] [Abstract][Full Text] [Related]
5. Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
Michel JB; Xu Y; Blot S; Philippe M; Chatellier G
J Cardiovasc Pharmacol; 1996 Jul; 28(1):142-8. PubMed ID: 8797148
[TBL] [Abstract][Full Text] [Related]
6. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
7. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
9. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
[TBL] [Abstract][Full Text] [Related]
10. Arthus C. Corcoran Memorial Lecture. Influence of nitric oxide and angiotensin II on renal involvement in hypertension.
Frohlich ED
Hypertension; 1997 Jan; 29(1 Pt 2):188-93. PubMed ID: 9039100
[TBL] [Abstract][Full Text] [Related]
11. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
12. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
14. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
15. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats.
Kashiwagi M; Shinozaki M; Hirakata H; Tamaki K; Hirano T; Tokumoto M; Goto H; Okuda S; Fujishima M
J Am Soc Nephrol; 2000 Apr; 11(4):616-624. PubMed ID: 10752520
[TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition.
Moreau P; Takase H; Küng CF; van Rooijen MM; Schaffner T; Lüscher TF
Stroke; 1995 Oct; 26(10):1922-8; discussion 1928-9. PubMed ID: 7570749
[TBL] [Abstract][Full Text] [Related]
19. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
Navarro-Cid J; Maeso R; Rodrigo E; Muñoz-García R; Ruilope LM; Lahera V; Cachofeiro V
Am J Hypertens; 1996 Nov; 9(11):1077-83. PubMed ID: 8931832
[TBL] [Abstract][Full Text] [Related]
20. Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats.
Nakata T; Takeda K; Harada S; Oguni A; Hatta T; Kawa T; Itoh H; Sasaki S; Nakagawa M
Hypertens Res; 2001 Jan; 24(1):39-45. PubMed ID: 11213029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
